[Aprotinin -- an allogeneic transfusion sparing drug].
Haas
S
S
Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München.
D000328:Adult; D000368:Aged; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001804:Blood Transfusion, Autologous; D005260:Female; D005340:Fibrinogen; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012306:Risk; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology
D006490:Hemostatics; D005340:Fibrinogen; D007611:Aprotinin